14th Meeting of the myocardial and Pericardial Diseases working group of the European society of cardiology (ESC)

14th Meeting of the myocardial and Pericardial Diseases working group of the European society of cardiology (ESC) is organized by Working Group on Myocardial Function and European Society of Cardiology (ESC) and would be held during Oct 26 - 28, 2017 at Hotel Nyborg Strand, Nyborg, Southern Denmark (Syddanmark), Denmark.

Healthcare professionals encounter diseases affecting the myocardium and pericardium in many varied clinical settings. A majority of the conditions are inherited with cardiomyopathies being most frequent and may manifest for the first time with sudden unexplained death in a young person, whereas others present with progressive symptoms or are detected accidentally following family screening. Likewise, the inflammatory and infective myocardial and pericardial diseases are also of significant importance in view of the challenges in making accurate diagnoses and the evolving novel therapeutic approaches using immunosuppressive and immunomodulatory therapies.

The aim of this meeting is to communicate progress in basic science and practical management of myocardial and pericardial diseases to a broad audience with an interest in the conditions including physicians, specialist nurses, clinical researchers, pathologists, geneticists, basic scientist and young investigators.

The meeting covers three days and is divided in two parts. The first day is dedicated to educational workshops with “How-to Sessions” and illustrative case study presentations. There will be a focus on genetics, imaging modalities including MRI, echocardiography and CT-scan, in addition to diagnosis and management of myocardial and pericardial diseases. There will also be sessions discussing the results of basic scientific research and the potential impact on clinical management and development of novel treatment modalities by use of gene therapy. The remaining two days will have a focus on specific topics including genetics in hereditary cardiac conditions, diagnosis and treatment of myocarditis and pericarditis, algorithms for implantable devices for management of arrhythmia and resynchronization therapy, novel algorithms for medical heart failure therapy, mechanical support of advanced heart failure, palliation, rare myocardial conditions including Anderson-Fabry disease and amyloidosis, sports-medicine and prevention of sudden cardiac death.

Additional details will be posted as soon as they are available.